James Anderson
Family Medicine · Irving, TXNPI 1225004351
Payments from drug & device makers
Across 180 payments — averaging $63.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$9K
- AbbVie$507
- Abbott$355
- GSK$254
- AstraZeneca$218
- Novo Nordisk$186
- plus $1K from 31 others
What the payments were for
- Consulting fees$6,01852%
- Travel & lodging$1,98717%
- Food & beverage$3,49930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 17 | $8,505 |
| AbbVie(2 entities) | 31 | $507 |
| Abbott | 17 | $355 |
| GSK | 15 | $254 |
| AstraZeneca | 13 | $218 |
| Novo Nordisk | 11 | $186 |
| Lilly USA, LLC | 13 | $167 |
| Stryker | 1 | $138 |
| Amgen | 5 | $118 |
| Amarin Pharma, Inc. | 4 | $90 |
| Cleerly, Inc. | 2 | $85 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $81 |
| Pfizer | 4 | $67 |
| Johnson & Johnson | 5 | $64 |
| Lundbeck LLC | 3 | $60 |
| Merck | 4 | $60 |
| Novartis | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Vertical Pharmaceuticals, LLC | 2 | $46 |
| Dexcom, Inc. | 2 | $38 |
| Mannkind Corporation | 3 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Bayer | 2 | $28 |
| Eisai Inc. | 1 | $25 |
| Astellas Pharma US Inc | 2 | $23 |
| Tris Pharma Inc | 1 | $23 |
| Viiv Healthcare Company | 1 | $22 |
| Abiomed | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Acrotech Biopharma Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Althera Pharmaceuticals LLC | 1 | $14 |
| GE HealthCare | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,504 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 24 | $31,623 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $13,122 |
| OzempicSemaglutide | 12 | $11,433 |
| TrintellixVortioxetine Hydrobromide | 11 | $10,162 |
| FarxigaDapagliflozin Propanediol | 11 | $8,497 |
| EliquisApixaban | 14 | $8,067 |
| Repatha SureclickEvolocumab | 11 | $5,796 |
| Testosterone Cypionate | 28 | $2,277 |
| ProgesteroneProgesterone, Micronized | 35 | $1,782 |
| Ezetimibe | 38 | $974 |
| Rosuvastatin Calcium | 52 | $552 |
| Tamsulosin Hcl | 17 | $405 |
| Allopurinol | 30 | $326 |
| Levothyroxine Sodium | 24 | $303 |
| Anastrozole | 71 | $283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $167 | $31,62324 claims |
| GSKTrelegy Ellipta | $254 | $13,12215 claims |
| Novo NordiskOzempic | $186 | $11,43312 claims |
| AstraZenecaFarxiga | $218 | $8,49711 claims |
| PfizerEliquis | $67 | $8,06714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Irving
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.